{"name":"Genosco Inc.","slug":"genosco-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"GNS-3545","genericName":"GNS-3545","slug":"gns-3545","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"GNS-3545","genericName":"GNS-3545","slug":"gns-3545","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPYXpPYnZsWFo3Q0xZT2VrZ01uUW5EMlhUdDFKSWdKYkZGeGlNSnd5ZEgxOUpVeU00cEdkanViWElaZkVwVVdFc1AyZnRPd1FSdWcxaWY0OW1UWXk4bWdaZGlOMXhwLTg3UVdyRFlpWmZNeDFPei1XTlhjQUVEd1FNetIBlAFBVV95cUxOTzI5anhvQWVyNDFMd1ZPaXViTFlndkZ2bnFLVTh6b0xkSWlvbDRSaVhGT0E5YXUyUm93VmJ5aUZoay1iYkNLcTNRdHN6MVRUeWppeVhNaldCaF82OEhKbEpwVi14RmhkenZkLVJhZ3E2cTZ6U3RRc1VNeHRxWC1sdVJ5a29IRF9OVWdoRGh1NUt6Vktf?oc=5","date":"2025-11-18","type":"regulatory","source":"Chosunbiz","summary":"Oscotec starts spin-off to buy remaining Genosco shares and secure control - CHOSUNBIZ - Chosunbiz","headline":"Oscotec starts spin-off to buy remaining Genosco shares and secure control - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNNkpZRmdDeEl1QmNhUVNUaU1lZHZQbTNUMEtkcGdPWTRnQmljY2lnLVVBdWh2b1F4R3QtRXNFRXBIMnBwQkJ3T1JTTFJXQUpGX1Itc3o3VENHM1d4Y1JaOUpiZ1VMdThTN3hRVG5wcU93bXIwdXBFSHdDajJnUG11aU5DdVRES003RkttSXhBb1NDTU1fdlBrNFZR?oc=5","date":"2025-09-09","type":"pipeline","source":"BioWorld News","summary":"South Korea INDs: Pimedbio, Sillajen, Genosco, SK Bio, Ami - BioWorld News","headline":"South Korea INDs: Pimedbio, Sillajen, Genosco, SK Bio, Ami","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPdGJaTjFtZURoZUtuV0JvZXpZcGo1LXRhRHRwZUIxWDhmWTRnZzM5ci12b2N0TVlLWUtvWlJvNVdHa3Q0NDRiZVFaVlFBUDVIYXdhRTFhaTF2dDBZR2MtaDZRU29UTDliNGNoOXBUSkJsa2F1T0tfYjgwTTZRc2paVNIBlAFBVV95cUxQdHZvWVFTOVNGbTFWNDluMDFrU0YtQWduYUx3U0lJaTNKaWRlMDA1QlRRTTRpWTZKQ3p1VndsY2M2MFBUcGNGZmQ5SzhjYU9EYmRqWUp6Yk9taHV3ajVDYVIzSEFqUHMxT3Faak8tLTh1cFdSTHhYQ1JHOWNEeXNOMlkxcHNXaXVfaUJ0ems4YmdJcE1q?oc=5","date":"2025-07-02","type":"pipeline","source":"Chosunbiz","summary":"Korea's pharmaceutical exports surge 28% as companies expand global presence - CHOSUNBIZ - Chosunbiz","headline":"Korea's pharmaceutical exports surge 28% as companies expand global presence - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE16dnBwWnhlTU5nblZuWW9KNFRsNWVzUE5VbF9JX2ladnZQd3F3RTNYZ25kcW9FX1BhaWo4VG1YQjYyZFdxYUN1TnZSUFpycDlKdDNxaHdqMnJCYnU3WU9MdHQzSU9XeDVvR01MaUlR0gFyQVVfeXFMTkxtU0tBUkdiLUkzbU9NUGYwS2RGSFp1QzhMb3ZIX09xbk1vY3dYQVhGTHpVRm1SczNFNVNUMmx5YmQ0aUtxbUItUjZtNzVBNklnbUZtcXVqZ1Y5a3dHM0JLcmRxYnNNTmgxa3lRRFJHVHFR?oc=5","date":"2025-04-14","type":"pipeline","source":"koreabiomed.com","summary":"Genosco faces Kosdaq listing setback. Will it pursue Nasdaq or a capital increase? - koreabiomed.com","headline":"Genosco faces Kosdaq listing setback. Will it pursue Nasdaq or a capital increase?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBPZXVXdnpzd1hidElkNC1acHZQSGhuR1NjS1NGM2psVWdCN0NjUXM2Rm1jeGxJVW9iX19TMnhCWEE3MkttQVNlSUpLNzZ4QVdydW1ZTjhSQlpud3RsYnhqYnlUUE1GTmJLWTQ1QlZR0gFyQVVfeXFMUDlCSTZ3eEZXQkZKS2JFTHNFbnlZeWdkTWJiN2tPYVdlOHBRT3Q2NkRLaDhIMW9ScHhaTk9iMDE3NF9SQ25aVmdhT1NYeHdHcGNmLVlhQjh1ZTJRZGpud2otQ1ZfSThrcHZXbzZCVFlOWGdB?oc=5","date":"2025-03-13","type":"pipeline","source":"koreabiomed.com","summary":"Oscotec faces investor backlash over Genesco IPO as CEO warns of R&D shutdown - koreabiomed.com","headline":"Oscotec faces investor backlash over Genesco IPO as CEO warns of R&D shutdown","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1jTHhGaFlvSWtFNnh2ODI4R1BMcllrb19fNWlINWZGS2ZrT2JUNEpEMThZTjRUbUZfQ2NCYkc2UlhTMFdLaFZNWFpRUTBuWlRVOHJQNWhyMTVNRjY3UXp2ejdqM0Y0UmM1MHdZQlF3?oc=5","date":"2024-08-21","type":"regulatory","source":"KED Global","summary":"Yuhan’s lung cancer drug clears FDA hurdle for global debut - KED Global","headline":"Yuhan’s lung cancer drug clears FDA hurdle for global debut","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBoY2cwSW91b2lCVHVHSGlyelVobm5DazZCc3QxdWt4Q0VWblJ2UHRNdjNCZFZ1Nnd0VXA3dmhXOEhrR21ab1Y0UTlQVTVsSjJCOWNsR3l3aE1oZWVLOHpPMEw0Y25XS0k?oc=5","date":"2023-06-06","type":"pipeline","source":"Market.us","summary":"Immune Thrombocytopenia Market Size | CAGR Of 0.89% - Market.us","headline":"Immune Thrombocytopenia Market Size | CAGR Of 0.89%","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}